Evaxion A (EVAX) EV to FCF (2021 - 2026)

Evaxion A (EVAX) EV to FCF (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EV to FCF
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -5.37 Mn
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -3.22 Mn
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -37,560.30
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -169,108.16
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -8,967.58
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 28.38
9 Abivax 94.37 Bn 94.37 Bn - -636.65
10 Regeneron Pharmaceuticals 63.60 Bn 54.85 Bn 3.31 Bn 13.33

Historic Data

Download Data
DateValue
Mar 30, 2026 -8,967.58
Mar 27, 2026 -8,372.68
Mar 26, 2026 -8,539.25
Mar 25, 2026 -8,801.00
Mar 24, 2026 -8,741.51
Mar 23, 2026 -9,229.33
Mar 20, 2026 -9,300.72
Mar 19, 2026 -9,514.88
Mar 18, 2026 -8,991.37
Mar 17, 2026 -9,110.35
Mar 16, 2026 -9,086.56
Mar 13, 2026 -10,133.58
Mar 12, 2026 -9,943.21
Mar 11, 2026 -9,205.54
Mar 10, 2026 -8,515.45
Mar 9, 2026 -7,325.65
Mar 6, 2026 -7,658.80
Mar 5, 2026 -8,087.13
Mar 4, 2026 -7,397.04
Mar 3, 2026 -7,420.84